Histology and immunophenotype of invasive lobular breast cancer. Daily practice and pitfalls

Breast Disease

Volumn 30, Issue , 2008, Pages 15-19

  Varga, Zsuzsanna ^a   Mallon, Elizabeth ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D; CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GROSS CYSTIC DISEASE FLUID PROTEIN 15; HORMONE RECEPTOR; KI 67 ANTIGEN; ONCOPROTEIN; PROTEIN P120; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER GRADING; CHROMOSOME 16Q; CLINICAL FEATURE; CLINICAL PRACTICE; DIFFERENTIAL DIAGNOSIS; GENE AMPLIFICATION; GENE OVEREXPRESSION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTRADUCTAL CARCINOMA; INVASIVE LOBULAR BREAST CANCER; INVASIVE LOBULAR BREAST CARCINOMA; PRIORITY JOURNAL; PROGNOSIS;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM GRADING; PROGNOSIS;

EID: 70350755892     PISSN: 08886008     EISSN: None     Source Type: Journal    
DOI: 10.3233/BD-2009-0278     Document Type: Article

References (19)

1. P. Rosen, Rosen's Breast Pathology, First ed., Lippincott-Raven, 1997.
2. S.J. Schnitt and L.C. Collins, Biopsy Interpretation of the Breast Biopsy Interpretation Series, 1009: Wolters Kluwer Health.
3. F.A. Tavassoli and P. Devilee, Tumours of the Breast and Female Genital Organs, IARC Press, Lyon, 2003.
4. F. Tavassoli, Pathology of the Breast, Appleton & Langem Stanford Connecticut, 1999.
5. E. Provenzano and S.E. Pinder, Pre-operative diagnosis of breast cancer in screening: Problems and pitfalls, Pathology 41(1) (2009), 3-17.
6. E.A. Rakha et al., Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast, Breast Cancer Res Treat 111(1) (2008), 121-127.
7. M.L. Talman, M.B. Jensen and F. Rank, Invasive lobular breast cancer. Prognostic significance of histological malignancy grading, Acta Oncol 46(6) (2007), 803-809.
8. G. Acs et al., Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications, Am J Clin Pathol 115(1) (2001), 85-98.
9. L. Da Silva et al., Aberrant expression of E-cadherin in lobular carcinomas of the breast, Am J Surg Pathol 32(5) (2008), 773-783.
10. D.J. Dabbs, R. Bhargava and M. Chivukula, Lobular versus ductal breast neoplasms: The diagnostic utility of p120 catenin, Am J Surg Pathol 31(3) (2007), 427-437.
11. O. Fadare, S.A. Wang and D. Hileeto, The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: Evidence of a basal-like subset? Hum Pathol 39(3) (2008), 331-336.
12. I.T. Yeh and C. Mies, Application of immunohistochemistry to breast lesions, Arch Pathol Lab Med 132(3) (2008), 349-358.
13. B.J. Yoder, E.J. Wilkinson and N.A. Massoll, Molecular and morphologic distinctions between infiltrating ductal and lobular carcinoma of the breast, Breast J 13(2) (2007), 172-179.
14. Z. Varga et al., Preferential HER-2/neu overexpression and/or amplification in aggressive histological subtypes of invasive breast cancer, Histopathology 44(4) (2004), 332-338.
15. D. Frolik, R. Caduff and Z. Varga, Pleomorphic lobular carcinoma of the breast: Its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas, Histopathology 39(5) (2001), 503-513.
16. R. Mahler-Araujo et al., Reduction of E-cadherin expression is associated with non-lobular breast carcinomas of basal-like and triple negative phenotype, J Clin Pathol 61(5) (2008), 615-620.
17. T. Moriya et al., The role of immunohistochemistry in the differential diagnosis of breast lesions, Pathology 41(1) (2009), 68-76.
18. B.C. Pestalozzi et al., Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: Combined results of 15 International Breast Cancer Study Group clinical trials, J Clin Oncol 26(18) (2008), 3006-3014.
19. X. Sastre-Garau et al., Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns, Cancer 77(1) (1996), 113-120.